Clinical Study of Progesterone Combined with Vitamin B6 in the Treatment of Amenorrhea Endocrine Disorders Caused by Antipsychotics
article
OA: hybrid
CC0
RETRACTED
Retraction notice. Marked retracted by OpenAlex; see publisher for the formal retraction notice.
AI-generated summary
Progesterone combined with vitamin B6 demonstrated superior effectiveness in treating antipsychotic-induced amenorrhea compared to progesterone alone, improving endocrine indices and uterine parameters.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: Endocrine disorders such as amenorrhea, lactation, and irregular menstruation caused by antipsychotics are common in female patients. How to reduce or eliminate these adverse reactions is a matter of concern. Objective: To evaluate the therapeutic effect of progesterone in combination with vitamin B6 in the treatment of antipsychotic-induced amenorrhea. Methods: In our hospital, from May 2019 to May 2021, 120 patients with amenorrhea caused by antipsychotics who underwent surgery were selected for this prospective study. The random residue grouping method divided them into a progesterone group (60 cases) and a vitamin B6 group (60 cases). Among them, the progesterone group was treated only with progesterone, while the vitamin B6 group was given progesterone in combination with vitamin B6. The differences in endocrine index, prolactin, uterine size, and endometrial thickness, effectiveness, and safety analysis of the progesterone and vitamin B6 groups of patients were observed and compared. Results: < 0.05). There were no adverse reactions in the progesterone and vitamin B6 groups. Conclusion: The effectiveness of progesterone combined with vitamin B6 in treating amenorrhea caused by antipsychotics is significantly better than simple progesterone, which can effectively improve the endocrine condition of patients and provide a reference for the clinical treatment of amenorrhea caused by antipsychotics.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (32)
- Progesterone receptor modulators for endometriosis via openalex
- doi:10.1007/s12020-019-02007-7 via openalex
- doi:10.1007/s12020-020-02315-3 via openalex
- doi:10.1093/ijnp/pyaa004 via openalex
- W2380854219 via openalex
- W2396763402 via openalex
- doi:10.3390/jcm10102075 via openalex
- doi:10.1155/2010/159402 via openalex
- doi:10.1055/s-0039-1696948 via openalex
- doi:10.1016/j.encep.2012.03.002 via openalex
- doi:10.1176/appi.ajp.2012.12050591 via openalex
- doi:10.1007/s11102-020-01039-x via openalex
- doi:10.1016/j.rpsm.2015.11.003 via openalex
- doi:10.1073/pnas.1015674108 via openalex
- doi:10.1016/j.schres.2017.03.019 via openalex
- doi:10.1080/09513590.2017.1320380 via openalex
- doi:10.1016/j.clinthera.2020.01.016 via openalex
- doi:10.14310/horm.2002.1313 via openalex
- doi:10.1097/gme.0000000000001480 via openalex
- doi:10.3748/wjg.14.498 via openalex
- doi:10.1016/j.rpsmen.2016.06.001 via openalex
- doi:10.1139/apnm-2019-0640 via openalex
- doi:10.1016/j.pop.2008.10.005 via openalex
- doi:10.1002/14651858.cd010770.pub2 via openalex
- doi:10.1176/appi.ajp.2012.11091432 via openalex
- doi:10.1007/s13224-019-01228-0 via openalex
- doi:10.1186/1687-9856-2010-159402 via openalex
- doi:10.1016/j.yfrne.2009.04.002 via openalex
- doi:10.1097/grf.0000000000000154 via openalex
- doi:10.1007/bf03345238 via openalex
- doi:10.1159/000479571 via openalex
- doi:10.1590/s0004-282x2004000100029 via openalex
Source provenance
- openalex
- last seen: 2026-05-13T18:22:30.807636+00:00
License: CC0
· commercial use OK